M&T Bank
TBIO

M&T Bank’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

M&T Bank’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-664
Closed -$129K – 1662
2021
Q4 		$129K Hold
664
– – ﹤0.01% 1494
2021
Q3 		$133K Hold
664
– – ﹤0.01% 1476
2021
Q2 		$263K Buy
+664
New +$235K ﹤0.01% 1322

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's TBIO Position: Q1 2022 in Review

M&T Bank sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022, closing a stake of 664 shares — an estimated $129K sold.

M&T Bank first reported a position in TBIO in Q2 2021 and held it in 3 quarters. The position peaked at $263K in Q2 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • M&T Bank reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • M&T Bank sold 664 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $129K.
  • M&T Bank first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • M&T Bank's Telesis Bio, Inc. Common Stock position peaked at $263K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on M&T Bank's 13F filing for Q1 2022, filed 9 May 2022.